What we offer
Technology-led end-to-end case processing, including case intake, data processing, quality, and medical review for submission to health authorities. We leverage AI/ML and NLP to speed and better understand the adverse events
Who is it for
Heads of drug safety and pharmacovigilance teams
Why it's important
Manage operations with preconfigured digitally assisted platform
Reduce manual effort and costs to create better control of AE
Transform AE process to interpret insights and enhance product safety at scale
How we deliver
We manage case intake from various channels, such as email, E2B R3, case forms (CIOMS, MedWatch), paper adverse events, call center, and affiliate cases with our proprietary platform and partner ecosystems.
Our experts leverage AI/ML and NLP technologies to extract and classify data, detect key entities (such as AEs, medical history, and patient-level information), and conduct medical coding. Our machineassisted quality and medical reviews ensure that the final outcome is compliant and accurate.
We assist translation of non-English documents and provision of last mile functionality, such as submission of cases to health authorities via E2B transmission, to enable faster turnaround time.